Reduced thrombin formation and excessive fibrinolysis are associated with bleeding complications in patients with dengue fever: A case-control study comparing dengue fever patients with and without bleeding manifestations

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Orsi, Fernanda A ^a   Angerami, Rodrigo N ^a   Mazetto, Bruna M ^a   Quaino, Susan K P ^a   Santiago Bassora, Fernanda ^a   Castro, Vagner ^a   de Paula, Erich V ^a   Annichino Bizzacchi, Joyce M ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Acquired coagulation disorders; Dengue fever; Dengue hemorrhagic fever; Fibrinolytic disorders; Infectious diseases; Thrombin generation; Thrombocytopenia

Indexed keywords

CELL MARKER; D DIMER; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLEEDING; CASE CONTROL STUDY; CELL ACTIVATION; CLINICAL FEATURE; CONTROLLED STUDY; DENGUE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; THROMBIN TIME; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FIBRINOLYSIS; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; SEVERE DENGUE; THROMBIN; YOUNG ADULT;

EID: 84880944358     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-350     Document Type: Article

References (37)

1. WHO Dengue guidelines for diagnosis, treatment, prevention and control 2009, Geneve: World Health Organization, WHO.
2. Kittigul L, Pitakarnjanakul P, Sujirarat D, Siripanichgon K. The differences of clinical manifestations and laboratory findings in children and adults with dengue virus infection. J Clin Virol 2007, 39(2):76-81. 10.1016/j.jcv.2007.04.006, 17507286.
3. Binh PT, Matheus S, Huong VT, Deparis X, Marechal V. Early clinical and biological features of severe clinical manifestations of dengue in Vietnamese adults. J Clin Virol 2009, 45(4):276-280. 10.1016/j.jcv.2009.04.004, 19451025.
4. Wills BA, Oragui EE, Stephens AC, Daramola OA, Dung NM, Loan HT, Chau NV, Chambers M, Stepniewska K, Farrar JJ, et al. Coagulation abnormalities in dengue hemorrhagic Fever: serial investigations in 167 Vietnamese children with Dengue shock syndrome. Clin Infect Dis 2002, 35(3):277-285. 10.1086/341410, 12115093.
5. Sosothikul D, Seksarn P, Pongsewalak S, Thisyakorn U, Lusher J. Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection. Thromb Haemost 2007, 97(4):627-634.
6. Wills B, Tran VN, Nguyen TH, Truong TT, Tran TN, Nguyen MD, Tran VD, Nguyen VV, Dinh TT, Farrar J. Hemostatic changes in Vietnamese children with mild dengue correlate with the severity of vascular leakage rather than bleeding. AmJTrop Med Hyg 2009, 81(4):638-644.
7. WHO Dengue haemorrhagic fever: diagnosis, treatment, prevention and control 1997, Geneva: World Health Organization, WHO.
8. Rigau-Perez JG. Severe dengue: the need for new case definitions. Lancet Infect Dis 2006, 6(5):297-302. 10.1016/S1473-3099(06)70465-0, 16631550.
9. Krishnamurti C, Kalayanarooj S, Cutting MA, Peat RA, Rothwell SW, Reid TJ, Green S, Nisalak A, Endy TP, Vaughn DW, et al. Mechanisms of hemorrhage in dengue without circulatory collapse. Am J Trop Med Hyg 2001, 65(6):840-847.
10. Deen JL, Harris E, Wills B, Balmaseda A, Hammond SN, Rocha C, Dung NM, Hung NT, Hien TT, Farrar JJ. The WHO dengue classification and case definitions: time for a reassessment. Lancet 2006, 368(9530):170-173. 10.1016/S0140-6736(06)69006-5, 16829301.
11. Nair SC, Dargaud Y, Chitlur M, Srivastava A. Tests of global haemostasis and their applications in bleeding disorders. Haemophilia 2010, 5(16):85-92.
12. Gerritsen HE, Turecek PL, Schwarz HP, Lammle B, Furlan M. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thromb Haemost 1999, 82(5):1386-1389.
13. Alexander N, Balmaseda A, Coelho IC, Dimaano E, Hien TT, Hung NT, Janisch T, Kroeger A, Lum LC, Martinez E, et al. Multicentre prospective study on dengue classification in four South-east Asian and three Latin American countries. Trop Med Int Health 2011, 16(8):936-948. 10.1111/j.1365-3156.2011.02793.x, 21624014.
14. Barniol J, Gaczkowski R, Barbato EV, Da Cunha RV, Salgado D, Martinez E, Segarra CS, Pleites Sandoval EB, Mishra A, Laksono IS, et al. Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries. BMC Infect Dis 2011, 11:106. 10.1186/1471-2334-11-106, 3098176, 21510901.
15. Narvaez F, Gutierrez G, Perez MA, Elizondo D, Nunez A, Balmaseda A, Harris E. Evaluation of the traditional and revised WHO classifications of Dengue disease severity. PLoS Negl Trop Dis 2011, 5(11):e1397. 10.1371/journal.pntd.0001397, 3210746, 22087348.
16. Halstead SB. Dengue in the Americas and Southeast Asia: do they differ?. Rev Panam Salud Publica 2006, 20(6):407-415. 10.1590/S1020-49892006001100007, 17341332.
17. Hammond SN, Balmaseda A, Perez L, Tellez Y, Saborio SI, Mercado JC, Videa E, Rodriguez Y, Perez MA, Cuadra R, et al. Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am J Trop Med Hyg 2005, 73(6):1063-1070.
18. Wichmann O, Hongsiriwon S, Bowonwatanuwong C, Chotivanich K, Sukthana Y, Pukrittayakamee S. Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand. Trop Med Int Health 2004, 9(9):1022-1029. 10.1111/j.1365-3156.2004.01295.x, 15361117.
19. Diaz-Quijano FA, Villar-Centeno LA, Martinez-Vega RA. Predictors of spontaneous bleeding in patients with acute febrile syndrome from a dengue endemic area. J Clin Virol 2010, 49(1):11-15. 10.1016/j.jcv.2010.06.011, 20663710.
20. Wang S, He R, Patarapotikul J, Innis BL, Anderson R. Antibody-enhanced binding of dengue-2 virus to human platelets. Virology 1995, 213(1):254-257. 10.1006/viro.1995.1567, 7483271.
21. Lin CF, Lei HY, Liu CC, Liu HS, Yeh TM, Wang ST, Yang TI, Sheu FC, Kuo CF, Lin YS. Generation of IgM anti-platelet autoantibody in dengue patients. J Med Virol 2001, 63(2):143-149. 10.1002/1096-9071(20000201)63:2<143::AID-JMV1009>3.0.CO;2-L, 11170051.
22. De Castro RA, De Castro JA, Barez MY, Frias MV, Dixit J, Genereux M. Thrombocytopenia associated with dengue hemorrhagic fever responds to intravenous administration of anti-D (Rh(0)-D) immune globulin. AmJTrop Med Hyg 2007, 76(4):737-742.
23. Saito M, Oishi K, Inoue S, Dimaano EM, Alera MT, Robles AM, Estrella BD, Kumatori A, Moji K, Alonzo MT, et al. Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections. Clin Exp Immunol 2004, 138(2):299-303. 10.1111/j.1365-2249.2004.02626.x, 1809201, 15498040.
24. Butthep P, Chunhakan S, Tangnararatchakit K, Yoksan S, Pattanapanyasat K, Chuansumrit A. Elevated soluble thrombomodulin in the febrile stage related to patients at risk for dengue shock syndrome. Pediatr Infect Dis J 2006, 25(10):894-897. 10.1097/01.inf.0000237918.85330.b9, 17006283.
25. Carr JM, Hocking H, Bunting K, Wright PJ, Davidson A, Gamble J, Burrell CJ, Li P. Supernatants from dengue virus type-2 infected macrophages induce permeability changes in endothelial cell monolayers. J Med Virol 2003, 69(4):521-528. 10.1002/jmv.10340, 12601760.
26. Huang YH, Lei HY, Liu HS, Lin YS, Liu CC, Yeh TM. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg 2000, 63(1-2):71-75.
27. Lin CF, Lei HY, Shiau AL, Liu CC, Liu HS, Yeh TM, Chen SH, Lin YS. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J Med Virol 2003, 69(1):82-90. 10.1002/jmv.10261, 12436482.
28. Chen HC, Hofman FM, Kung JT, Lin YD, Wu-Hsieh BA. Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol 2007, 81(11):5518-5526. 10.1128/JVI.02575-06, 1900309, 17360740.
29. Basu A, Chaturvedi UC. Vascular endothelium: the battlefield of dengue viruses. FEMS Immunol Med Microbiol 2008, 53(3):287-299. 10.1111/j.1574-695X.2008.00420.x, 18522648.
30. Huang YH, Liu CC, Wang ST, Lei HY, Liu HL, Lin YS, Wu HL, Yeh TM. Activation of coagulation and fibrinolysis during dengue virus infection. J Med Virol 2001, 63(3):247-251. 10.1002/1096-9071(200103)63:3<247::AID-JMV1008>3.0.CO;2-F, 11170065.
31. Mairuhu AT, Mac Gillavry MR, Setiati TE, Soemantri A, Ten Cate H, Brandjes DP, Van Gorp EC. Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence. Lancet Infect Dis 2003, 3(1):33-41. 10.1016/S1473-3099(03)00487-0, 12505032.
32. Van Gorp EC, Setiati TE, Mairuhu AT, Suharti C, Cate Ht H, Dolmans WM, Van Der Meer JW, Hack CE, Brandjes DP. Impaired fibrinolysis in the pathogenesis of dengue hemorrhagic fever. J Med Virol 2002, 67(4):549-554. 10.1002/jmv.10137, 12116003.
33. Funahara Y, Sumarmo, Shirahata A, Setiabudy-Dharma R. DHF characterized by acute type DIC with increased vascular permeability. Southeast Asian J Trop Med Public Health 1987, 18(3):346-350.
34. Tripodi A, Chantarangkul V, Mannucci PM. Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing. Br J Haematol 2009, 147(1):77-82. 10.1111/j.1365-2141.2009.07833.x, 19659548.
35. Tripodi A, Primignani M, Lemma L, Chantarangkul V, Dell'Era A, Iannuzzi F, Aghemo A, Mannucci PM. Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method. Hepatology 2010, 52(1):249-255. 10.1002/hep.23653, 20578143.
36. Uszynski M. Amniotic fluid embolism: the complication of known pathomechanism but without pathogenetic therapy?. Thromb Haemost 2009, 101(5):795-796.
37. Lin SW, Chuang YC, Lin YS, Lei HY, Liu HS, Yeh TM. Dengue virus nonstructural protein NS1 binds to prothrombin/thrombin and inhibits prothrombin activation. J Infect 2011, 64(3):325-334.